Curis
CRIS
#10252
Rank
C$32.51 M
Marketcap
C$0.81
Share price
-2.15%
Change (1 day)
-62.89%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2025 (TTM): C-$5.20

According to Curis's latest financial reports the company's current EPS (TTM) is C-$5.02. In 2024 the company made an earnings per share (EPS) of C-$9.61 an increase over its 2023 EPS that were of C-$12.34.

EPS history for Curis from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C-$5.20-45.88%
2024C-$9.61-22.15%
2023C-$12.34-26.17%
2022C-$16.7222.3%
2021C-$13.67-25.37%
2020C-$18.32-30.93%
2019C-$26.52-2.02%
2018C-$27.06
2016C-$61.51-10%
2015C-$68.34138.1%
2014C-$28.7040%
2013C-$20.50-25%
2012C-$27.3466.67%
2011C-$16.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.86-137.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$4.73-194.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.49-90.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$3.95-178.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$5.32 5.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$15.36 206.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C$1.93-138.42%๐Ÿ‡บ๐Ÿ‡ธ USA